Toru Terashima

Director/Board Member at SAWAI GROUP HOLDINGS CO., LTD.

64 year

Health Technology

Profile

Toru Terashima currently works at Sawai Pharmaceutical Co., Ltd., as Director & Managing Executive Officer from 2019 and SAWAI GROUP HOLDINGS Co., Ltd., as Director & Managing Executive Officer from 2021.

Toru Terashima active positions

Companies	Position	Start
SAWAI GROUP HOLDINGS CO., LTD.	Director/Board Member	2021-03-31
Sawai Pharmaceutical Co., Ltd. Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan.	Director/Board Member	2017-05-31

All active positions of Toru Terashima

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Toru Terashima's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SAWAI GROUP HOLDINGS CO., LTD.	Health Technology

Private companies	1
Sawai Pharmaceutical Co., Ltd. Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan.	Health Technology